Vexol Articles
Biotech Promise For Rheumatoid Arthritis
26 February 1998
Fast FDA Approvals Of User-Fee NMEs In 1994
16 January 1995
Alcon's Vexol Approved In USA
9 January 1995
Showing 1-3 of 3 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
